Trial Outcomes & Findings for Omega Tots Long Term Follow-up (NCT NCT05191823)

NCT ID: NCT05191823

Last Updated: 2026-08-11

Results Overview

Differential Ability Scales-II General Conceptual Ability assessment is a measure of general cognitive ability and is used to assess and identify children's cognitive strengths and weaknesses. The general cognitive ability score has a range from 30 to 170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance.

Recruitment status

ACTIVE_NOT_RECRUITING

Study phase

NA

Target enrollment

377 participants

Primary outcome timeframe

A single study visit when the child is between 8.5 years to 10.5 years

Results posted on

2026-08-11

Participant Flow

Participant milestones

Participant milestones
Measure
Docosahexaenoic Acid + Arachidonic Acid
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Overall Study
STARTED
189
188
Overall Study
COMPLETED
158
152
Overall Study
NOT COMPLETED
31
36

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Omega Tots Long Term Follow-up

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=189 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=188 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Total
n=377 Participants
Total of all reporting groups
Age, Continuous
9.2 years
n=54 Participants
9.3 years
n=54 Participants
9.2 years
n=27 Participants
Sex: Female, Male
Female
84 Participants
n=54 Participants
98 Participants
n=54 Participants
182 Participants
n=27 Participants
Sex: Female, Male
Male
105 Participants
n=54 Participants
90 Participants
n=54 Participants
195 Participants
n=27 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=54 Participants
0 Participants
n=54 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Asian
2 Participants
n=54 Participants
1 Participants
n=54 Participants
3 Participants
n=27 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=54 Participants
0 Participants
n=54 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Black or African American
52 Participants
n=54 Participants
53 Participants
n=54 Participants
105 Participants
n=27 Participants
Race (NIH/OMB)
White
114 Participants
n=54 Participants
122 Participants
n=54 Participants
236 Participants
n=27 Participants
Race (NIH/OMB)
More than one race
21 Participants
n=54 Participants
12 Participants
n=54 Participants
33 Participants
n=27 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=54 Participants
0 Participants
n=54 Participants
0 Participants
n=27 Participants
Region of Enrollment
United States
189 participants
n=54 Participants
188 participants
n=54 Participants
377 participants
n=27 Participants

PRIMARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

Differential Ability Scales-II General Conceptual Ability assessment is a measure of general cognitive ability and is used to assess and identify children's cognitive strengths and weaknesses. The general cognitive ability score has a range from 30 to 170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=156 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=151 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
General Cognitive Ability Score(Differential Ability Scales, Second Edition-DAS-II)
94.3 score on a scale
Standard Deviation 14.8
96.9 score on a scale
Standard Deviation 16.6

PRIMARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

Clinical evaluation of Language Fundamentals, 5th edition core tests is a comprehensive measure of language and can assess children's written and oral language skills, as well as their reading comprehension. The core language score has a range from 30 to 170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=156 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=152 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Core Language Score (Clinical Evaluation of Language Fundamentals, Fifth Edition-CELF-5)
93.2 score on a scale
Standard Deviation 14.8
92.8 score on a scale
Standard Deviation 17.1

PRIMARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

Population: Some participants did not take part in this protocol component.

The NIH Toolbox Cognition Battery is a multi-dimensional set of brief measures assessing cognitive function. The Flanker, Dimensional Card Sort, and Pattern Comparison subtests measure executive function, processing speed, and attention. Standard scores have a range from 30 to 170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance..

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=152 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=148 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Executive Function (NIH Toolbox)
92.4 standard score
Standard Deviation 12.3
91.2 standard score
Standard Deviation 12.3

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The Grooved Pegboard task measures eye-hand coordination and motor speed by requiring children to insert pegs into a board. The score is the time to place the pegs. If the child reaches the time limit of 3 minutes, then the score is the number of pegs placed. A faster time and lower number of pegs dropped is indicative of better performance.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=158 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=152 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Grooved Pegboard Task
104.8 seconds
Standard Deviation 31.2
102 seconds
Standard Deviation 29.1

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The Weschler Intelligence Scales for Children-V Digit Span and Picture Span subtests assess working memory. The working memory index composite score has a range from 30-170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=154 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=149 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Select Subtest From the Wechsler Intelligence Scales for Children, Fifth Edition (WISC-V)
94.6 score on a scale
Standard Deviation 15
93.6 score on a scale
Standard Deviation 16.1

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The Kaufman Test of Educational Achievement-3 is an assessment of key academic skills. The Letter and Word Recognition, Math Computation, Object Naming Facility, and Associative Fluency Subtests measure children's reading, math, and written language skills. The standard score has a range from 30-170 (mean=100; SD=15). A low score indicates poor performance, and a high score indicates best performance.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=155 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=151 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Select Subtests From the Kaufman Test of Educational Achievement, Third Edition (KTEA-3)
91.5 score on a scale
Standard Deviation 18.1
94.3 score on a scale
Standard Deviation 16.8

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

To assess children's body composition, height (in centimeters) is measured. This is converted to a z score for age and sex based on Child Growth Standards from the World Health Organization. The z score indicates the number of standard deviations away from the mean. A z score of 0 is equal to the mean of a reference population (children the same age and sex). Values less than 0 indicate values lower than the reference population, while values greater than 0 indicate values higher than the reference population.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=155 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=145 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Anthropometrics-Body Composition (Height)
.23 z-score
Standard Deviation 1.03
.29 z-score
Standard Deviation 1.01

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

To assess children's body composition, weight (in kilograms) is measured. This is converted to a z score for age and sex based on Child Growth Standards from the World Health Organization. The z score indicates the number of standard deviations away from the mean. A z score of 0 is equal to the mean of a reference population (children the same age and sex). Values less than 0 indicate values lower than the reference population, while values greater than 0 indicate values higher than the reference population.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=155 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=147 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Anthropometrics-Body Composition (Weight)
.66 z-score
Standard Deviation 1.22
.66 z-score
Standard Deviation 1.21

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

To assess children's adiposity, a bioelectric impedance is used to measure body fat percent. Child's height and weight will be combined to report BMI (kg/m\^2). These measurements are converted to a z score for age and sex based on Child Growth Standards from the World Health Organization. The z score indicates the number of standard deviations away from the mean. A z score of 0 is equal to the mean of a reference population (children the same age and sex). Values less than 0 indicate values lower than the reference population, while values greater than 0 indicate values higher than the reference population.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=155 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=145 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Anthropometrics-Adiposity
.73 z-score
Standard Deviation 1.28
.69 z-score
Standard Deviation 1.19

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The Behavior Rating Inventory of Executive Function, 2nd ed., is completed by the child's caregiver and teacher to measure a range of executive functioning capabilities in children. The BRIEF-2 yields nine clinical scales that measure various aspects of executive function plus three broad indices: behavioral regulation, emotion regulation, and cognitive regulation. Scores are summed to obtain a Global Executive Composite Score that will be expressed as a t score (range= \[35-90\]; (mean=50; SD=10), where a higher score indicates greater dysregulation .

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=160 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=155 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Behavior Rating Inventory of Executive Function, 2nd Edition (BRIEF-2)
55.4 t-score
Standard Deviation 11.3
56.9 t-score
Standard Deviation 11.7

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The Teacher Report Form (syndrome and DSM-Oriented subscales) is completed by the child's teacher to reflect on the child's behavior in the previous six months. Scores are summed to provide a total problems score. Scores are also computed to measure the following subscales: internalizing problems, externalizing problems, anxious/depressed, withdrawn/depressed, somatic complaints, social problems, thought problems, attention problems, rule-breaking behavior, aggression behavior, affective problems, anxiety problems, somatic problems, attention deficit/hyperactivity problems, oppositional defiant problems, conduct problems. Scores will be expressed as a t-score (range= \[33-100\]; mean=50; SD=10), where a lower score indicates a more optimal outcome.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=132 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=137 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Select Subscales From the Teacher Report Form 6-18
51.1 score on a scale
Standard Deviation 8.8
52.6 score on a scale
Standard Deviation 9.2

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The Child Behavior Checklist is completed by the child' caregiver to reflect their child's behavior in the previous six months. Scores were summed to provide total competence score. Total competence scores will be expressed as a t-score (range= \[20-100\]; mean=50; SD=10), where a higher score reflects a more optimal outcome.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=159 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=156 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Child Behavior Checklist 6-18 (CBCL) - Competence
39.6 t-score
Standard Deviation 10.1
40.7 t-score
Standard Deviation 10.0

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The National Survey of Children's Health module captures child developmental and behavioral diagnoses and other major diagnoses via parent report . A binary variable will be formed to indicate if a child has been diagnosed with each condition or not (yes, no).

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=156 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
National Survey of Children's Health Module - Learning Disability
33 Participants
33 Participants

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The Emotion Regulation Checklist is completed by the child's caregiver to measure child's ability to manage their emotions. Scores are grouped and summed to yield Emotion Regulation scale (range=10-40). Higher scores on the Emotion Regulation scale indicates more ability to regulate

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=156 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=161 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Emotion Regulation Checklist - Emotion Regulation
26.3 score on a scale
Standard Deviation 3.9
25.9 score on a scale
Standard Deviation 3.7

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The NIH Toolbox Friendship (Ages 8-17) Fixed Form is a 5-item questionnaire that measures peer relationships and assesses the quality of relationships with friends and other acquaintances over the past month. Scores will be expressed as a t-score (range= \[16-68\]; mean=50; SD=10), where a higher score indicates stronger peer relationships.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=157 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=152 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
NIH Toolbox Friendship Fixed Form
44.4 t-score
Standard Deviation 10.3
44.9 t-score
Standard Deviation 9.5

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The NIH Toolbox Positive Peer Interaction Form (Ages 3-12) is a 4-item questionnaire that measures child peer relationships via parent report. Scores will be expressed as a t-score (range= \[-8-63\] ; mean=50; SD=10), where a higher score indicates stronger peer relationships.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=157 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=152 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
NIH Toolbox Positive Peer Interaction Parent Report Fixed Form
46.7 t-score
Standard Deviation 10.6
47.5 t-score
Standard Deviation 11.4

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The Child Sleep Habits Questionnaire-abbreviated measures child sleep pattern and behaviors via parent report. Parents are asked to report on the child's bedtime behavior, sleep duration, and behavior during sleep. Scores are summed to give the total sleep disturbance score (range 33-99). Scores are also grouped and summed to yield eight subscales that measure different aspects of sleep. A higher score is indicative of more sleep problems .

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=156 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Child Sleep Habits Questionnaire-abbreviated Measure
38.2 score on a scale
Standard Deviation 5.1
38.6 score on a scale
Standard Deviation 4.6

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The Child Behavior Checklist is completed by the child' caregiver to reflect their child's behavior in the previous six months. Scores were summed to provide problem scores. T Problem scores will be expressed as a t-score (range= \[25,100\]; mean=50; SD=10), where a lower score reflects a more optimal outcome.

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=156 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Child Behavior Checklist 6-18 (CBCL) - Problems
51.7 t-score
Standard Deviation 12.0
52.6 t-score
Standard Deviation 11.4

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The National Survey of Children's Health module captures child developmental and behavioral diagnoses and other major diagnoses via parent report . A binary variable will be formed to indicate if a child has been diagnosed with each condition or not (yes, no).

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=156 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
National Survey of Children's Health Module - Developmental Delay
46 Participants
43 Participants

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The National Survey of Children's Health module captures child developmental and behavioral diagnoses and other major diagnoses via parent report . A binary variable will be formed to indicate if a child has been diagnosed with each condition or not (yes, no).

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=156 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
National Survey of Children's Health Module - INtellectual Disability
2 Participants
6 Participants

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The National Survey of Children's Health module captures child developmental and behavioral diagnoses and other major diagnoses via parent report . A binary variable will be formed to indicate if a child has been diagnosed with each condition or not (yes, no).

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=156 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
National Survey of Children's Health Module - Speech or Other Language Disorder
43 Participants
32 Participants

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The National Survey of Children's Health module captures child developmental and behavioral diagnoses and other major diagnoses via parent report . A binary variable will be formed to indicate if a child has been diagnosed with each condition or not (yes, no).

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=156 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
National Survey of Children's Health Module - Behavioral or Conduct Problems
29 Participants
30 Participants

SECONDARY outcome

Timeframe: A single study visit when the child is between 8.5 years to 10.5 years

The Emotion Regulation Checklist is completed by the child's caregiver to measure child's ability to manage their emotions. Scores are grouped and summed to yield a Lability/Negativity (range=14-56) scale. Higher scores on the Lability/Negativity scale reflect greater dysregulation .

Outcome measures

Outcome measures
Measure
Docosahexaenoic Acid + Arachidonic Acid
n=161 Participants
Docosahexaenoic Acid + Arachidonic Acid (DHA+AA) Docosahexaenoic Acid + Arachidonic Acid (DHA+AA): 200 mg DHA+ 200 mg AA per day for 6 months
Placebo
n=156 Participants
Corn oil supplement Placebo: 400 mg corn oil per day for 6 months
Emotion Regulation Checklist - Lability/Negativity
26.0 score on a scale
Standard Deviation 6.7
26.4 score on a scale
Standard Deviation 6.6

Adverse Events

Adverse Events Were Not Assessed During This Follow-up Study

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sarah Keim, Principal Investigator

Nationwide Children's Hospital

Phone: 6147222000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place